SUN PHARMACEUTICAL INDUSTRIES INC
- UPDATE 1-Japan's Daiichi Sankyo to sell up to $3.6 bln Sun Pharma stake Reuters - Sectors - Healthcare
- Sun Pharma closes merger deal with Ranbaxy Clinical Trials Today [CenterWatch]
- Sun Pharma Announces Closure of Merger Deal with Ranbaxy Pharmpro News
- India's Sun Pharma open to large acquisitions post Ranbaxy deal Reuters - Sectors - Healthcare
- Ranbaxy sale to Sun Pharmaceuticals appears on track Fierce Pharma Manufacturing
- UPDATE 1-Sun Pharmaceutical wins U.S. approval to buy Ranbaxy Reuters - Sectors - Healthcare
- India's Sun Pharma looks ahead on verge of Ranbaxy deal approval Fierce Pharma
- Sun closes in on Ranbaxy deal with CCI approval In-Pharma Technologist
- India's regulator clears Sun Pharma-Ranbaxy deal Reuters - Markets - Deals
- Ranbaxy Laboratories Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg Bio Space - Breaking News
Alerts on more than 5,000 companies today, including:
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on SUN PHARMACEUTICAL INDUSTRIES INC
- Rate SUN PHARMACEUTICAL INDUSTRIES INC on their payment behavior
- Ask your network about SUN PHARMACEUTICAL INDUSTRIES INC with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.